UoS-led study offers new hope for cancer patients

An international study led by a researcher at the University of Sharjah (UoS) has uncovered groundbreaking findings that may reshape the treatment approach for multiple myeloma, a type of blood cancer.

- 

The study demonstrated that listening to patients' self-reported assessments of their physical functioning prior to starting treatment with daratumumab can help predict how well they will respond to therapy.

The study was led by Dr Ahmad Abuhelwa, Assistant Professor at the College of Pharmacy, University of Sharjah, and involved 1,804 patients with multiple myeloma across three major international clinical trials. The research was conducted in collaboration with Burjeel Cancer Institute in the UAE, Flinders University in Australia, Moffitt Cancer Center, and the University of North Carolina in the United States.